RPTX Stock Analysis: Buy, Sell, or Hold?
RPTX - Repare Therapeutics Inc. Common Shares
$2.65
0.02 (0.76%)
▲
BUY
MODERATE Confidence
Last Updated: January 27, 2026
Earnings: Mar 03, 2026
29d
Get Alerted When RPTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RPTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RPTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RPTX is currently trading at $2.65, which is considered slightly high relative to its 30-day fair value range of $2.40 to $2.66.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.40 -
$2.66
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
Protect Your Profits
RPTX is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($3.00)
Fair Price Analysis
30-Day Fair Range
$2.40 -
$2.66
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$2.65
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.63
Wall Street Target
$3.00
(+13.2%)
Revenue Growth (YoY)
-76.7%
Last updated: February 01, 2026 1:25 AM ET
Data refreshes hourly during market hours. Next update: 2:25 AM
Data refreshes hourly during market hours. Next update: 2:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
Advanced RPTX Option Strategies
Professional options setups generated by AI based on today's RPTX price and gamma walls.
